Explore all that Huvepharma, Inc. has to offer! Like us on Facebook and subscribe to our Youtube channel.
In July 2019, Huvepharma had the opportunity to bring the first bioequivalent monensin product (Monovet® 90 monensin Type A medicated article) to U.S.
5 Steps to take when receiving calves from the Southeast
To flip the switch on the damage done by BRD, prevention and vaccinations are key.
August 28, 2018 (Peachtree City, GA) – Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.
